Evidence map›Paper›PMID 29984189›Full record

ArticleToxicology reports2018

Glutathione and Inter-α-trypsin inhibitor heavy chain 3 (Itih3) mRNA levels in nicotine-treated Cd44 knockout mice.

Rochelle N Wickramasekara, Seth Morrill, Yasmine Farhat, Sarah J Smith, Deniz Yilmazer-Hanke

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Rochelle N WickramasekaraDepartment of Biomedical Sciences, School of Medicine, Creighton University, Omaha, Nebraska, USA.
Seth MorrillDepartment of Biomedical Sciences, School of Medicine, Creighton University, Omaha, Nebraska, USA.
Yasmine FarhatDepartment of Biomedical Sciences, School of Medicine, Creighton University, Omaha, Nebraska, USA.
Sarah J SmithDepartment of Biomedical Sciences, School of Medicine, Creighton University, Omaha, Nebraska, USA.
Deniz Yilmazer-HankeDepartment of Biomedical Sciences, School of Medicine, Creighton University, Omaha, Nebraska, USA.
Creighton University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cluster of differentiation 44 (Cd44), a hyaluronan receptor, and the secreted hyaluronan-binding protein Inter-α-trypsin Inhibitor Heavy chain 3 (Itih3) play an important role in cancer and oxidative stress. Smoking of tobacco reduces Itih3 in the plasma and activates hyaluronan signaling through Cd44, but the impact of Cd44 on Itih3 expression is unknown. Here, we studied changes induced by the tobacco component nicotine on the glutathione (GSH) antioxidant system and Itih3 gene expression in Cd44 knockout mice. Cd44 deficiency decreased baseline total GSH and oxidized glutathione (GSSG) levels in the liver compared to wildtype mice. However, contrary to wildtype mice, chronic oral nicotine administration (200 μg/ml) failed to further reduce total GSH and GSSG in Cd44 mice. Sex differences with lowered glutathione levels in females was also detectable only in wildtype but not Cd44 knockout mice. Itih3 mRNA levels in the liver and hypothalamus were not affected by nicotine, Cd44 genotype or sex. Nonetheless, the correlation between Itih3 and total GSH levels in the liver (r = 0.42, p < 0.05) suggested a role of Itih3 in glutathione metabolism in WT mice. Again this effect was diminished in Cd44 knockout mice. The disappearance of nicotine effects, sex differences and correlations between Itih3 and total GSH in Cd44 knockout mice compared to wildtype animals suggests an interaction between nicotine, Cd44 and/or sex-dependent signaling in the regulation of glutathione metabolism.

Indexed as

4-Vinylpyridine (7502)5,5′-Dithiobis(2-nitrobenzoic acid) or DTNB (6254)5-Sulfosalicylic acid dihydrate (2723734)Chronic oral nicotine treatmentDimethyl sulfoxide or DMSO (679)GenderHepatic diseaseHyaluronan receptorl-Glutathione oxidized or oxiglutatione, also GSSG (65359)l-Glutathione reduced, also GSH (124886)l-Nicotine (89594)Oxidative stressPre-Alpha-Inhibitorβ-Nicotinamide adenine dinucleotide 2′-phosphate or NADPH (16218775)

Identifiers

PMID29984189
PMCPMC6031235
OpenAlexW2809526091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.